Home > PE Ratio > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SOTAC PHARMACEUTICALS is 42.94.

Share Price ₹115.0May 30,2024
Market Cap ₹127.7 Cr
Earnings-TTM₹3.0 CrTTM-Consolidated Results
Price/Earnings42.94xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of SOTAC PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SOTAC PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹127.7 Cr] as on May 30,2024

(/) Earnings [ ₹3.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 42.94x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SOTAC PHARMACEUTICALS , the investors are currently willing to pay 42.94 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SOTAC PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SOTAC PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SOTAC PHARMACEUTICALS


PE Ratio Performance Analysis for SOTAC PHARMACEUTICALS

- SOTAC PHARMACEUTICALS 's latest p/e ratio is 42.94x.

- SOTAC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 0.00x.

- SOTAC PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, SOTAC PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 0x.

- SOTAC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does SOTAC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SOTAC PHARMACEUTICALS 2.9742.94127.7
SUN PHARMACEUTICAL INDUSTRIES LTD9,648.4436.31350,339.0
CIPLA LTD4,155.3128.14116,930.0
DR REDDYS LABORATORIES LTD5,563.2017.3596,546.9
ZYDUS LIFESCIENCES LTD3,831.4026.28100,694.0
DIVIS LABORATORIES LTD1,600.0071.51114,416.0
MANKIND PHARMA LTD1,926.5544.6385,978.3
TORRENT PHARMACEUTICALS LTD1,656.0055.1191,258.4
LUPIN LTD1,935.5737.4072,388.0
AUROBINDO PHARMA LTD3,186.1321.8369,550.9
ABBOTT INDIA LTD1,201.2245.7754,984.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SOTAC PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.35x
Max industry PE 71.51x
Median industry PE 37.40x
Average industry PE 38.84x



You may also like the below Video Courses